Topical treatments for peripheral neuropathic pain — providing local analgesia with minimal systemic absorption reducing systemic side effects that limit oral neuropathic pain medications — represent a growing market segment, with the Peripheral Neuropathy Market reflecting topical analgesic advancement as an important peripheral neuropathy treatment evolution....
As cancer survival rates improve, the "Long-Term Side Effects" of treatment are coming into sharper focus. In 2026, the Peripheral Neuropathy Market is seeing a steady increase in cases of "Chemotherapy-Induced Peripheral Neuropathy" (CIPN). Many life-saving cancer drugs are unfortunately "Neurotoxic," meaning they can damage the nerves in the hands and feet as they fight the tumor. In 2026,...